INDP - Indaptus Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

INDP is currently covered by 2 analysts with an average price target of $8.27. This is a potential upside of $7.21 (680.19%) from yesterday's end of day stock price of $1.06.

Indaptus Therapeutics's activity chart (see below) currently has 2 price targets and 10 ratings on display. The stock rating distribution of INDP is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for INDP is $12, Lowest price target is $5, average price target is $8.27.

Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 13-Nov-2024. First documented stock forecast 20-Oct-2021.

Best performing analysts who are covering INDP - Indaptus Therapeutics:

Raghuram Selvaraju Jason Mccarthy

Currently out of the existing stock ratings of INDP, 8 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$5

$3.89 (350.45%)

$8

8 days ago
(13-Nov-2024)

0/4 (0%)

$3.85 (334.78%)

Buy

$12

$10.89 (981.08%)

$12

1 months 5 days ago
(16-Oct-2024)

0/5 (0%)

$10.57 (739.16%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is INDP (Indaptus Therapeutics) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on INDP (Indaptus Therapeutics) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the current lower performing score on INDP (Indaptus Therapeutics) with a proven track record?

JASON MCCARTHY

Which analyst has the most public recommendations on INDP (Indaptus Therapeutics)?

Raghuram Selvaraju has 3 price targets and 17 ratings on INDP

Which analyst is the currently most bullish on INDP (Indaptus Therapeutics)?

Raghuram Selvaraju with highest potential upside - $10.89

Which analyst is the currently most reserved on INDP (Indaptus Therapeutics)?

Jason Mccarthy with lowest potential downside - $3.89

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?